SZSE:300318 (China)
Â
Class A
Â¥
5.38
(-1.47%)
Jan 15
Business Description
Beijing Bohui Innovation Biotechnology Group Co Ltd
NAICS : 333999
SIC : 3829
ISIN : CNE000001QR4
Share Class Description:
SZSE:300318: Class ACompare
Compare
Traded in other countries / regions
300318.China IPO Date
2012-05-23Description
Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 0.72 | |||||
| Debt-to-EBITDA | 10.69 | |||||
| Interest Coverage | 2.97 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.81 | |||||
| Beneish M-Score | -2.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.2 | |||||
| 3-Year EBITDA Growth Rate | 11.2 | |||||
| 3-Year FCF Growth Rate | 19.5 | |||||
| 3-Year Book Growth Rate | 1.8 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.4 | |||||
| 9-Day RSI | 38.67 | |||||
| 14-Day RSI | 38.57 | |||||
| 6-1 Month Momentum % | 27.36 | |||||
| 12-1 Month Momentum % | 5.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.26 | |||||
| Quick Ratio | 0.28 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 729.3 | |||||
| Days Sales Outstanding | 19.72 | |||||
| Days Payable | 204.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -2.78 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.52 | |||||
| Operating Margin % | 9.39 | |||||
| Net Margin % | -1.73 | |||||
| FCF Margin % | -19.35 | |||||
| ROE % | -1.1 | |||||
| ROA % | -0.39 | |||||
| ROIC % | 1.75 | |||||
| 3-Year ROIIC % | 490.16 | |||||
| ROC (Joel Greenblatt) % | 4.85 | |||||
| ROCE % | 3.18 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.98 | |||||
| PB Ratio | 3.15 | |||||
| Price-to-Tangible-Book | 20.69 | |||||
| Price-to-Operating-Cash-Flow | 206.92 | |||||
| EV-to-EBIT | 67.57 | |||||
| EV-to-EBITDA | 67.57 | |||||
| EV-to-Revenue | 7.16 | |||||
| EV-to-FCF | -36.37 | |||||
| Price-to-Median-PS-Value | 0.58 | |||||
| Earnings Yield (Greenblatt) % | 1.48 | |||||
| FCF Yield % | -3.9 | |||||
| Forward Rate of Return (Yacktman) % | -20.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Bohui Innovation Biotechnology Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 885.392 | ||
| EPS (TTM) (Â¥) | -0.019 | ||
| Beta | 0.94 | ||
| Volatility % | 39.47 | ||
| 14-Day RSI | 38.57 | ||
| 14-Day ATR (Â¥) | 0.232866 | ||
| 20-Day SMA (Â¥) | 5.744 | ||
| 12-1 Month Momentum % | 5.32 | ||
| 52-Week Range (Â¥) | 3.43 - 7.17 | ||
| Shares Outstanding (Mil) | 816.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Bohui Innovation Biotechnology Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Bohui Innovation Biotechnology Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Bohui Innovation Biotechnology Group Co Ltd Frequently Asked Questions
What is Beijing Bohui Innovation Biotechnology Group Co Ltd(SZSE:300318)'s stock price today?
The current price of SZSE:300318 is ¥5.38. The 52 week high of SZSE:300318 is ¥7.17 and 52 week low is ¥3.43.
When is next earnings date of Beijing Bohui Innovation Biotechnology Group Co Ltd(SZSE:300318)?
The next earnings date of Beijing Bohui Innovation Biotechnology Group Co Ltd(SZSE:300318) is .
Does Beijing Bohui Innovation Biotechnology Group Co Ltd(SZSE:300318) pay dividends? If so, how much?
Beijing Bohui Innovation Biotechnology Group Co Ltd(SZSE:300318) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers